Discover
CRGX
CARGO Therapeutics, Inc.
4.47
undefined x undefined
undefined x undefined
bid
ask
+
0.00
0.00%
04:00 PM
| Ytd | ||
| 1y |
4.47
day range
4.47
12.17
52 week range
33.92
| Open | 4.53 | Prev Close | 4.47 | Low | 4.47 | High | 4.47 | Mkt Cap | 677.53M |
| Vol | 9.53M | Avg Vol | 224.14K | EPS | -17.59 | P/E | N/A | Forward P/E | -3.16 |
| Beta | N/A | Short Ratio | 28.85 | Inst. Own | 109.63% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 18.56 | 200-d Avg | 19.11 | 1yr Est | 31.71 |
| Income Statement | |||
| Operating Expenses | 52.90M | ||
| Research and Development Expense | 7.51M | ||
| Selling, General and Administrative Expense | 8.29M | ||
| Operating Income | -52.90M | ||
| Net Income | -49.94M | ||
| Net Income Common Stock | -49.94M | ||
| Net Income Common Stock (USD) | -49.94M | ||
| Consolidated Income | -49.94M | ||
| Earnings per Basic Share | -1.04 | ||
| Earnings per Basic Share (USD) | -1.04 | ||
| Earnings per Diluted Share | -1.04 | ||
| Earning Before Interest & Taxes (EBIT) | -49.94M | ||
| Earning Before Interest & Taxes (USD) | -49.94M | ||
| Weighted Average Shares | 48.13M | ||
| Weighted Average Shares Diluted | 48.13M | ||
| Balance Sheet | |||
| Cash and Equivalents | 108.31M | ||
| Cash and Equivalents (USD) | 108.31M | ||
| Investments | 144.82M | ||
| Investments Current | 144.82M | ||
| Current Assets | 258.61M | ||
| Total Assets | 258.61M | ||
| Debt Current | 578.00K | ||
| Total Debt | 578.00K | ||
| Current Liabilities | 20.91M | ||
| Total Liabilities | 20.91M | ||
| Accumulated Retained Earnings (Deficit) | -447.08M | ||
| Accumulated Other Comprehensive Income | -9.00K | ||
| Shareholders Equity | 237.70M | ||
| Shareholders Equity (USD) | 237.70M | ||
| Total Debt (USD) | 578.00K | ||
| Trade and Non-Trade Payables | 8.67M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 572.00K | ||
| Net Cash Flow from Financing | 5.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 45.98M | ||
| Capital Expenditure | -99.00K | ||
| Issuance (Purchase) of Equity Shares | 5.00K | ||
| Net Cash Flow from Investing | 123.36M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 124.46M | ||
| Net Cash Flow from Operations | -77.38M | ||
| Share Based Compensation | 5.26M | ||